Genetics

Research shows hope for personalized genome sequencing

Imagine if you could carry a credit card-size record of all the 3 billion A's, T's C's, and G's that make up the alphabet soup of your genome. A simple swipe of the card could inform your physician right away if a drug being ...

Oncology & Cancer

New method for investigating and classifying liver tumours

Adenomas are rare liver tumours, a certain percentage of which can become malignant. Using a new MR (magnetic resonance) technique at MedUni Vienna, it is now possible to classify adenomas without subjecting patients to invasive ...

Alzheimer's disease & dementia

Amyloid pet may lead to better treatment for Alzheimer's patients

New research presented during the 2015 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) demonstrates that amyloid positron emission tomography (amyloid PET) scans of the brain provide clearer ...

Alzheimer's disease & dementia

Cloud-based neuroimaging analysis could aid Alzheimer's diagnosis

Alzheimer's disease remains a chronic, incurable neurodegenerative disease and a worldwide health concern. Equally as important as developing comprehensive diagnostic tests is finding a means of normalizing all the ensuing ...

Oncology & Cancer

PET/CT captures hidden source of neuroendocrine cancer

The origin of cancer is often obscured by metastases—tumors that have already spread to other tissues. This is especially the case for neuroendocrine tumors (NETs), a malignancy of nerve cells scattered throughout various ...

Cardiology

Amyloid scan of the heart predicts major cardiac events

Amyloid build-up is commonly talked about in relation to Alzheimer's disease, but amyloidosis can be found throughout the body. An excessive accumulation of these insoluble proteins could cause a heart attack or even death. ...

Oncology & Cancer

Theranostic PET takes on both ovarian and prostate cancer

A first-in-human study revealed at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) shows how a powerful new drug finds and attaches itself to the ovarian and prostate cancer cells ...

Oncology & Cancer

Hybrid scanner combines five molecular imaging technologies

Scientists are taking medical imaging research and drug discovery to a new level by developing a molecular imaging system that combines several advanced technologies for all-in-one imaging of both tissue models and live subjects, ...

page 13 from 24